Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FF/VI for Asthma in Asian Patients
NCT01498679Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2012
- Primary completion
- Jul 2013
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 3 trial of fluticasone, vilanterol trifenatate in asthma, sponsored by GSK. Started Jan 2012; status: completed.
02
Drugs
fluticasonevilanterol trifenatate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01498679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01498679.